Table 1 Primers used in the study
From: Anti-erbB2 treatment induces cardiotoxicity by interfering with cell survival pathways
Gene | Primers |
|---|---|
ErbB-2 | 5'-TGGTGGTCGTTGGAATCCTAATC-3' 5'-CCAGCCATCACATACGCTTCATC-3' |
ErbB-3 | 5'-GGTGCCAAAGGTCCAATCTA C-3' 5'-ACCGTCACCGCTATTACCAG-3' |
ErbB-4 | 5'-CACAACCAGCACCATACCAG-3' 5'-TTCATCCAGTTCTGCTCGTG-3' |
Neuregulin | 5'-GAAGGCGCAAACACTTCTTC-3' 5'-TTGGCAACGATCACCAGTAA-3' |
gp130 | 5'-TGAAGACAGACCATCCAAAGCG-3' 5'-CCATTCTACCCAGAGCAGGTTATC-3' |
Calreticulin | 5'-TCCCTGACCCTGATGCTAAGAAG-3' |
| Â | 5'-ATTGTGCCAGACTTGACCTGCC-3' |
Calsequestrin | 5'-CCAGAGCATCTGTGGACTCA-3' 5'-AGCCAGCAGACCTGAACAGT-3' |
β-actin | 5'-TTGTAACCAACTGGGACGATATGG-3' 5'-GATCTTGATCTTCATGGTGCTAGG-3' |